Abstract
MicroRNAs (miRNAs) play crucial roles in the progression of different tumors. In our study, we investigated the expression and roles of miR-411 in human osteosarcoma. In this study, we first confirmed that the miR-411 expression was higher in the serum of patients with osteosarcoma than in the serum of healthy volunteers. In addition, we found that the miR-411 expression was upregulated in the osteosarcoma tissues compared to that in the matched normal bone tissues. We also demonstrated that the miR-411 expression was upregulated in the four osteosarcoma cell lines. Elevated expression of miR-411 promoted osteosarcoma cell proliferation and migration. Moreover, we identified that metastasis suppressor protein 1 (MTSS1) was a direct target gene of miR-411 in the osteosarcoma cell. We also demonstrated that the MTSS1 expression was downregulated in the osteosarcoma tissues compared to that in the matched normal bone tissues. In addition, MTSS1 expression level was inversely correlated with miR-411 expression in the osteosarcoma tissues. Furthermore, elevated expression of miR-411 enhanced the osteosarcoma cell proliferation and migration through inhibiting the MTSS1 expression. These data suggested that miR-411 played as oncogene in the osteosarcoma partly by inhibiting the MTSS1 expression.
Similar content being viewed by others
Change history
09 April 2024
Editor's Note: Readers are alerted that the concerns have been raised with this article. Editorial action will be taken as appropriate once this matter is resolved and all parties have been given an opportunity to respond in full.
References
Ahmad A, Sethi S, Chen W, Ali-Fehmi R, Mittal S, Sarkar FH (2014) Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis. Am J Transl Res 6(4):384–390
Du P, Ye L, Li H, Yang Y, Jiang WG (2012) The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway. J Exp Ther Oncol 10(2):91–99
Guo L, Yuan J, Xie N, Wu H, Chen W, Song S, Wang X (2016) miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer. Mol Med Rep 14(4):2975–2982. https://doi.org/10.3892/mmr.2016.5645
Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R (2013) MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8(1):e55502. https://doi.org/10.1371/journal.pone.0055502
Kang M, Ren MP, Zhao L, Li CP, Deng MM (2015) miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1. Am J Transl Res 7(11):2212–2222
Kelly AD, Haibe-Kains B, Janeway KA, Hill KE, Howe E, Goldsmith J, Kurek K, Perez-Atayde AR, Francoeur N, Fan JB, April C, Schneider H, Gebhardt MC, Culhane A, Quackenbush J, Spentzos D (2013) MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. Genome Med 5(1):2. https://doi.org/10.1186/gm406
Lam DC, Girard L, Suen WS, Chung LP, Tin VP, Lam WK, Minna JD, Wong MP (2006) Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers. J Thorac Oncol 1(9):932–942. https://doi.org/10.1016/S1556-0864(15)31624-5
Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J, Liang Y, Xiao J, Wang HY, Yang Q, Hu G (2014) Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene 33(10):1287–1296. https://doi.org/10.1038/onc.2013.65
Li P, Xue WJ, Feng Y, Mao QS (2015) MicroRNA-205 functions as a tumor suppressor in colorectal cancer by targeting cAMP responsive element binding protein 1 (CREB1). Am J Transl Res 7(10):2053–2059
Liu J, Yan J, Zhou C, Ma Q, Jin Q, Yang Z (2014) miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma. Tumour Biol
Liu QL, Zhang J, Liu X, Gao JY (2015) Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway. Cell Prolif 48(5):573–581. https://doi.org/10.1111/cpr.12206
Martinez-Pacheco M, Hidalgo-Miranda A, Romero-Cordoba S, Valverde M, Rojas E (2014) MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects. Gene 533(2):508–514. https://doi.org/10.1016/j.gene.2013.09.049
Niu G, Li B, Sun J, Sun L (2015) miR-454 is down-regulated in osteosarcomas and suppresses cell proliferation and invasion by directly targeting c-Met. Cell Prolif 48(3):348–355. https://doi.org/10.1111/cpr.12187
Nixdorf S, Grimm MO, Loberg R, Marreiros A, Russell PJ, Pienta KJ, Jackson P (2004) Expression and regulation of MIM (missing in metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett 215(2):209–220. https://doi.org/10.1016/j.canlet.2004.05.002
Pei H, Jin Z, Chen S, Sun X, Yu J, Guo W (2015) MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1. Mol Cell Biochem 400(1-2):245–252. https://doi.org/10.1007/s11010-014-2281-2
Shan TD, Ouyang H, Yu T, Li JY, Huang CZ, Yang HS, Zhong W, Xia ZS, Chen QK (2016) miRNA-30e regulates abnormal differentiation of small intestinal epithelial cells in diabetic mice by downregulating Dll4 expression. Cell Prolif 49(1):102–114. https://doi.org/10.1111/cpr.12230
Shen L, Chen XD, Zhang YH (2014a) MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol 35(3):2069–2074. https://doi.org/10.1007/s13277-013-1274-1
Shen L, Wang P, Yang J, Li X (2014b) MicroRNA-217 regulates WASF3 expression and suppresses tumor growth and metastasis in osteosarcoma. PLoS One 9(10):e109138. https://doi.org/10.1371/journal.pone.0109138
Sun Z, Zhang T, Hong H, Liu Q, Zhang H (2014) miR-202 suppresses proliferation and induces apoptosis of osteosarcoma cells by downregulating Gli2. Molecular and cellular biochemistry 397(1-2):277–283. https://doi.org/10.1007/s11010-014-2195-z
Tang J, Shen L, Yang Q, Zhang C (2014) Overexpression of metadherin mediates metastasis of osteosarcoma by regulating epithelial-mesenchymal transition. Cell Prolif 47(5):427–434. https://doi.org/10.1111/cpr.12129
Vrba L, Munoz-Rodriguez JL, Stampfer MR, Futscher BW (2013) miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 8(1):e54398. https://doi.org/10.1371/journal.pone.0054398
Wang F, Xiao W, Sun J, Han D, Zhu Y (2014a) MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma. Tumour Biol 35(9):8653–8658. https://doi.org/10.1007/s13277-014-2131-6
Wang J, Xu G, Shen F, Kang Y (2014b) miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol 35(5):4859–4865. https://doi.org/10.1007/s13277-014-1637-2
Wang G, Li B, Fu Y, He M, Wang J, Shen P, Bai L (2015a) miR-23a suppresses proliferation of osteosarcoma cells by targeting SATB1. Tumour Biol
Wang L, Shao J, Zhang X, Xu M, Zhao J (2015b) microRNA-377 suppresses the proliferation of human osteosarcoma MG-63 cells by targeting CDK6. Tumour Biol
Wang Y, Jia LS, Yuan W, Wu Z, Wang HB, Xu T, Sun JC, Cheng KF, Shi JG (2015c) Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Am J Transl Res 7(1):111–119
Wang P, Xu J, Hou Z, Wang F, Song Y, Wang J, Zhu H, Jin H (2016) miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA. Cell Prolif 49(4):484–493. https://doi.org/10.1111/cpr.12265
Woodings JA, Sharp SJ, Machesky LM (2003) MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 371(2):463–471. https://doi.org/10.1042/bj20021962
Wu S, Du X, Wu M, Du H, Shi X, Zhang T (2016) MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-delta1. Gene 584(1):83–89. https://doi.org/10.1016/j.gene.2016.03.021
Xia K, Zhang Y, Cao S, Wu Y, Guo W, Yuan W, Zhang S (2015) miR-411 regulated ITCH expression and promoted cell proliferation in human hepatocellular carcinoma cells. Biomed Pharmacother Biomed Lharmacother 70:158–163
Xu L, Zhong J, Guo B, Zhu Q, Liang H, Wen N, Yun W, Zhang L (2016) miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1. Tumour Biol 37(9):12023–12032. https://doi.org/10.1007/s13277-016-5058-2
Yamamoto K, Seike M, Takeuchi S, Soeno C, Miyanaga A, Noro R, Minegishi Y, Kubota K, Gemma A (2014) MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma. Oncol Rep 32(6):2365–2372. https://doi.org/10.3892/or.2014.3481
Yang G, Zhang P, Lv A, Liu Y, Wang G (2016) MiR-205 functions as a tumor suppressor via targeting TGF-alpha in osteosarcoma. Exp Mol Pathol 100(1):160–166. https://doi.org/10.1016/j.yexmp.2015.12.010
Yu Z, Zhang Y, Gao N, Wang X (2015) Overexpression of miR-506 inhibits growth of osteosarcoma through Snail2. Am J Transl Res 7(12):2716–2723
Zhang S, Qi Q (2015) MTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastoma. J Neuro-Oncol 121(3):425–431. https://doi.org/10.1007/s11060-014-1656-2
Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV, Yang Q, Chan CS, Feng Z (2014a) MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling. Oncotarget 5(19):9106–9117. https://doi.org/10.18632/oncotarget.2379
Zhang C, Yao C, Li H, Wang G, He X (2014b) Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol 7(7):4194–4203
Zhang ZY, Fu SL, Xu SQ, Zhou X, Liu XS, Xu YJ, Zhao JP, Wei S (2015) By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer. Oncotarget 6(3):1462–1477. https://doi.org/10.18632/oncotarget.2808
Zhang S, Zhao Y, Wang L (2016a) MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1. Biochem Biophys Res Commun 472(3):557–565. https://doi.org/10.1016/j.bbrc.2016.03.040
Zhang Y, Xu G, Liu G, Ye Y, Zhang C, Fan C, Wang H, Cai H, Xiao R, Huang Z, Luo Q (2016b) miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochem Biophys Res Commun 476(4):607–613. https://doi.org/10.1016/j.bbrc.2016.06.006
Zhang YD, Xu GX, Liu G, Ye YZ, Zhang CK, Fan CN, Wang HB, Cai HL, Xiao R, Huang ZJ, Luo Q (2016c) miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. Biochem Biophys Res Commun 476(4):607–613. https://doi.org/10.1016/j.bbrc.2016.06.006
Zhao H, Xue J, Liu J, Liu Y, Cheng Y (2016a) Effect of metastasis suppressor 1 on H1299 cells and its clinical significance in non-small cell lung cancer. Oncol Rep 36(5):2814–2822. https://doi.org/10.3892/or.2016.5081
Zhao Z, Qin L, Li S (2016b) miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1. Tumour Biol 37(4):5551–5560. https://doi.org/10.1007/s13277-015-4425-8
Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J (2014) miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J Exp Clin Cancer Res CR 33:12
Acknowledgements
This work was supported by The Scientific Research Innovation Foundation of the First Affiliated Hospital of Harbin Medical University (Grant No.2017B021) and The Scientific Research Project of Health and Family Planning Commission of Heilongjiang Province (Grant No.2017-052) and The General Program of the Natural Science Foundation of Heilongjiang Province (Grant No.JJ2018ZRO199).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the Ethic Committee of The First Affiliated Hospital of Harbin Medical University and informed consent was obtained from each patient.
Additional information
Responsible editor: Philippe Garrigues
Electronic supplementary material
Table S1
(DOCX 12 kb)
Rights and permissions
About this article
Cite this article
Xu, N., Yang, W., Liu, Y. et al. MicroRNA-411 promoted the osteosarcoma progression by suppressing MTSS1 expression. Environ Sci Pollut Res 25, 12064–12071 (2018). https://doi.org/10.1007/s11356-018-1331-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-018-1331-9